3 completed. 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Bay Area Retina Associates: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification Bevacizumab, Ranibizumab, Aflibercept - Diabetic Macular Edema, Cataract | Phase 4 | Completed | Bay Area Retina Associates | 16 | 2018-11-15 | 2025-09-12 |
| A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD ranibizumab and dexamethasone, Ranibizumab - Exudative Age-Related Macular Degeneration | Phase 1 / Phase 2 | Completed | Subhransu K. Ray, M.D., Ph.D. | 40 | 2008-01-01 | 2012-12-19 |
| Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration ranibizumab, dexamethasone and verteporfin, Ranibizumab - Age Related Macular Degeneration | Phase 2 | Completed | Bay Area Retina Associates | 60 | 2006-08-01 | 2010-05-27 |
Cataract (1) · Macular Degeneration (1) · Retinal Degeneration (1)
Dexamethasone (3) · Ranibizumab (3) · Bevacizumab (1) · Calcium Dobesilate (1) · Verteporfin (1) · aflibercept (1)
United States (3)
Subhransu K Ray, M.D., Ph.D. (2) · Caesar Luo, MD (1)